Search Results - "Demecheleer, E."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice by Symons, J., Vandekerckhove, L., Paredes, R., Verhofstede, C., Bellido, R., Demecheleer, E., van Ham, P.M., van Lelyveld, S.F.L., Stam, A.J., van Versendaal, D., Nijhuis, M., Wensing, A.M.J.

    Published in Clinical microbiology and infection (01-06-2012)
    “…Guidelines state that the CCR5-inhibitor Maraviroc should be prescribed to patients infected with R5-tropic HIV-1 only. Therefore, viral tropism needs to be…”
    Get full text
    Journal Article
  2. 2

    Markers associated with persisting low-level viraemia under antiretroviral therapy in HIV-1 infection by Vancoillie, Leen, Demecheleer, Els, Callens, Steven, Vogelaers, Dirk, Vandekerckhove, Linos, Mortier, Virginie, Verhofstede, Chris

    Published in Journal of antimicrobial chemotherapy (01-04-2014)
    “…Objectives To identify host and viral characteristics associated with long-term persisting low-level viraemia (PLLV) under antiretroviral therapy (ART)…”
    Get full text
    Journal Article
  3. 3

    CXCR4-Using HIV Type 1 Variants Are More Commonly Found in Peripheral Blood Mononuclear Cell DNA Than in Plasma RNA by Verhofstede, Chris, Vandekerckhove, Linos, Eygen, Veerle Van, Demecheleer, Els, Vandenbroucke, Ina, Winters, Bart, Plum, Jean, Vogelaers, Dirk, Stuyver, Lieven

    “…OBJECTIVE:To compare the distribution of R5-like and X4-like HIV-1envelope sequences in plasma and peripheral blood mononuclear cell (PBMC). METHODS:Clonal…”
    Get full text
    Journal Article
  4. 4
  5. 5

    A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance by Steegen, Kim, Demecheleer, Els, De Cabooter, Nancy, Nges, Dieudonné, Temmerman, Marleen, Ndumbe, Peter, Mandaliya, Kishor, Plum, Jean, Verhofstede, Chris

    Published in Journal of virological methods (01-05-2006)
    “…Quantification of the viral burden and identification of drug resistant mutations are important laboratory tools in the management of HIV-1 infected patients…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Impact of 32-CCR5 heterozygosity on HIV-1 genetic evolution and variability-A study of 4 individuals infected with closely related HIV-1 strains by Chalmet, K, Van Wanzeele, F, Demecheleer, E, Dauwe, K, Pelgrom, J, Van Der Gucht, B, Vogelaers, D, Plum, J, Stuyver, L, Vandekerckhove, L, Verhofstede, C

    Published in Virology (New York, N.Y.) (30-09-2008)
    “…A cluster of four patients acutely infected with a genetically almost identical virus, allowed us to investigate genetic variability and disease progression in…”
    Get full text
    Journal Article
  9. 9

    Effect of didanosine, zalcitabine and abacavir on lamivudine resistant virus with the M184V mutation by Verhofstede, C, Van Wanzeele, F, Van Der Gucht, B, De Cabooter, N, Demecheleer, E, Plum, J

    Published in AIDS (London) (01-10-2000)
    “…Substitution of methionine (M) with valine (V) at the 184 codon of the HIV-1 reverse transcriptase consistently results in high-level (1000-fold) resistance…”
    Get full text
    Journal Article